Maxime Barakat

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Replacement Therapy

Respiratory Syndrome Coronavirus

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Giulia Morsica, Emanuela Messina, Sabrina Bagaglio, Laura Galli, Riccardo Lolatto, Michela Sampaolo, Maxime Barakat, Robert J Israel, Antonella Castagna, Nicola Clementi
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia. Microorganisms 12 (6) (2024)
Giulia Morsica, Emanuela Messina, Sabrina Bagaglio, Laura Galli, Riccardo Lolatto, Michela Sampaolo, Maxime Barakat, Robert J Israel, Antonella Castagna, Nicola Clementi
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia. Microorganisms 12 (6) (2024)
Garyfallia Poulakou, Maxime Barakat, Robert J Israel, Marcelo R Bacci, null null
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial. Clinical and translational science (2022)
Peter Couroux, Alexandre Brkovic, Jason L Vittitow, Robert J Israel, Chinna Pamidi, Jignesh Patel, Maxime Barakat
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin. Clinical and translational science 15 (9) (2022)